Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

456 ARTÍCULOS , VIENDO DEL 61 AL 75

Cognitive impairment in studies of 5HTTLPR and psychosis in Alzheimer's disease: a systematic review

Creese B, Ballard C, Jones E.

Dement Geriatr Cogn Disord. 2013;35(3-4):155-64. doi: 10.1159/000346733. Epub 2013 Feb 5.

Validity of criteria for dementia in older people with intellectual disability

Strydom A, Chan T, Fenton C, Jamieson-Craig R, Livingston G, Hassiotis A.

Am J Geriatr Psychiatry. 2013 Mar;21(3):279-88. doi: 10.1016/j.jagp.2012.11.017.

Change of accent as an atypical onset of non fluent primary progressive aphasia

Paolini S, Paciaroni L, Manca A, Rossi R, Fornarelli D, Cappa SF, Abbatecola AM, Scarpino O.

Behav Neurol. 2013;27(2):221-7. doi: 10.3233/BEN-120299.

Sporadic Jakob-Creutzfeldt disease presenting as primary progressive aphasia

Johnson DY, Dunkelberger DL, Henry M, Haman A, Greicius MD, Wong K, DeArmond SJ, Miller BL, Gorno-Tempini ML, Geschwind MD.

JAMA Neurol. 2013 Feb;70(2):254-7. doi: 10.1001/2013.jamaneurol.139.

Midlife obesity and dementia: meta-analysis and adjusted forecast of dementia prevalence in the United States and China

Loef M, Walach H.

Obesity (Silver Spring). 2013 Jan;21(1):E51-5. doi: 10.1002/oby.20037.

Visual reproduction on the Wechsler Memory Scale-Revised as a predictor of Alzheimer's disease in Japanese patients with mild cognitive impairments

Hori T, Sanjo N, Tomita M, Mizusawa H.

Dement Geriatr Cogn Disord. 2013;35(3-4):165-76. doi: 10.1159/000346738. Epub 2013 Feb 8.

Apolipoprotein E4 genotype does not increase risk of HIV-associated neurocognitive disorders

Morgan EE, Woods SP, Letendre SL, Franklin DR, Bloss C, Goate A, Heaton RK, Collier AC, Marra CM, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Ellis RJ, Abramson I, Gamst A, Fennema-Notestine C, Smith DM, Grant I, Vaida F, Clifford DB; CNS HIV Antiretroviral Therapy Effects Research (CHARTER) Group.

J Neurovirol. 2013 Apr;19(2):150-6. doi: 10.1007/s13365-013-0152-3. Epub 2013 Feb 14.

Genetic variation in clusterin gene and Alzheimer's disease risk in Han Chinese

Yu JT, Ma XY, Wang YL, Sun L, Tan L, Hu N, Tan L.

Neurobiol Aging. 2013 Jul;34(7):1921.e17-23. doi: 10.1016/j.neurobiolaging.2013.01.010. Epub 2013 Feb 12.

Efficacy of a cognitive intervention program in patients with mild cognitive impairment

Rojas GJ, Villar V, Iturry M, Harris P, Serrano CM, Herrera JA, Allegri RF.

Int Psychogeriatr. 2013 May;25(5):825-31. doi: 10.1017/S1041610213000045. Epub 2013 Feb 18.

Two cases of loss of consciousness after long-term memantine treatment

Savić A, Mimica N.

J Am Med Dir Assoc. 2013 May;14(5):375-6. doi: 10.1016/j.jamda.2013.01.010. Epub 2013 Feb 14.

Predicting AD conversion: comparison between prodromal AD guidelines and computer assisted PredictAD tool

Liu Y, Mattila J, Ruiz MÁ, Paajanen T, Koikkalainen J, van Gils M, Herukka SK, Waldemar G, Lötjönen J, Soininen H; Alzheimer's Disease Neuroimaging Initiative.

PLoS One. 2013;8(2):e55246. doi: 10.1371/journal.pone.0055246. Epub 2013 Feb 12.

Novel evidence of phenotypical variability in the hexanucleotide repeat expansion in chromosome 9

Cerami C, Marcone A, Galimberti D, Zamboni M, Fenoglio C, Serpente M, Scarpini E, Cappa SF.

J Alzheimers Dis. 2013;35(3):455-62. doi: 10.3233/JAD-122302.

A 12-week multidomain intervention versus active control to reduce risk of Alzheimer's disease: study protocol for a randomized controlled trial

Anstey KJ, Bahar-Fuchs A, Herath P, Rebok GW, Cherbuin N.

Trials. 2013 Feb 27;14:60. doi: 10.1186/1745-6215-14-60.

Special issue on advances and controversies in B vitamins and choline

Herrmann W, Obeid R.

Clin Chem Lab Med. 2013 Mar 1;51(3):455-6. doi: 10.1515/cclm-2013-0004.

The omega-6/omega-3 ratio and dementia or cognitive decline: a systematic review on human studies and biological evidence

Loef M, Walach H.

J Nutr Gerontol Geriatr. 2013;32(1):1-23. doi: 10.1080/21551197.2012.752335.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias